F-star Therapeutics
(NASDAQ) FSTX
F-star Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$21.18M
Net Income (TTM)
$44.99M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FSTX News
FSTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout F-star Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
88
CEO
Eliot Richard Forster, PhD, MBA
Website
www.f-star.comHeadquarters
Cambridge, CB22 3AT, GB
FSTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-45%
Return on Capital
-28%
Return on Assets
-25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$21.17M
Operating Income
$30.71M
EBITDA
$29.42M
Operating Cash Flow
$27.27M
Capital Expenditure
$658.00K
Free Cash Flow
$27.93M
Cash & ST Invst.
$78.55M
Total Debt
$13.23M
F-star Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$1.13M
+49.8%
Gross Profit
$1.13M
+49.8%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
84
N/A
Net Income
$18.47M
-71.1%
EBITDA
$17.78M
-80.7%
Quarterly Fundamentals
Net Cash
$22.89M
-60.3%
Accounts Receivable
$8.14M
+320.3%
Inventory
$0.00
N/A
Long Term Debt
$10.54M
-15.1%
Short Term Debt
$2.14M
+119.4%
Return on Assets
-25.43%
N/A
Return on Invested Capital
-27.70%
N/A
Free Cash Flow
$16.59M
-54.8%
Operating Cash Flow
$16.55M
-54.4%